Energy News / Shareholders Foundation, Inc.

NYSE: TEVA Long Term Investor Alert: Investigation of Potential Wrongdoing at Teva Pharmaceutical Industries Limited

Via: ReleaseWire

Updated 11:00 AM CST, Thu, November 07,2019

An investigation on behalf of current long term investors in Teva Pharmaceutical Industries Limited (NYSE: TEVA) shares over possible breaches of fiduciary duty by certain officers and directors was announced.

San Diego, CA -- (SBWIRE) -- 11/07/2019 -- Certain directors of Teva Pharmaceutical Industries Limited are under investigation concerning potential breaches of fiduciary duties.

Investors who are current long term investors in Teva Pharmaceutical Industries Limited (NYSE: TEVA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NYSE: TEVA stocks follows a lawsuit filed against Teva Pharmaceutical Industries Limited over alleged securities laws violations. The investigation on behalf of current long term investors in NYSE: TEVA stocks, concerns whether certain Teva Pharmaceutical Industries Limited directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Eastern District of Pennsylvania the plaintiff alleges that the defendants made false and/or misleading statements denying that Teva "engaged in any conduct that would give rise to liability" in various antitrust proceedings and investigations that enveloped the company. In truth, and as Defendants failed to disclose to investors, (i) contrary to its public denials, Teva had in fact engaged in a vast, industry-wide price-fixing scheme and other collusive misconduct since at least 2012; (ii) Teva was not only a participant, but the company at the heart of the anticompetitive scheme; and (iii) several Teva employees had such deep involvement in the scheme that they would ultimately be named personally as defendants in a sweeping civil enforcement action filed by the AGs of virtually every state in the nation.

Those who purchased shares of Teva Pharmaceutical Industries Limited (NYSE: TEVA) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit:
http://www.sbwire.com/press-releases/nyse-teva-long-term-investor-alert-investigation-potential-1264456.htm

Media Relations Contact
Michael Daniels
1-858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com